Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysis (Q30251862)

13 June 2017

1 reference

1 reference

Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysis (English)

1 reference

13 June 2017

0 references

1 reference

1 reference

Keith Sabin

5

0 references

Homie Razavi

object named as

Homie Razavi

8

0 references

Peter Vickerman

object named as

Peter Vickerman

9

0 references

Catherine C. McGowan

6

object named as

Catherine McGowan

1 reference

13 June 2017

2

Philippa Easterbrook

1 reference

13 June 2017

Lucy Platt

1

1 reference

13 June 2017

Erin Gower

3

1 reference

13 June 2017

Bethan McDonald

4

1 reference

13 June 2017

Irini Yanny

7

1 reference

13 June 2017

24 February 2016

1 reference

Lancet Infectious Diseases

13 June 2017

1 reference

13 June 2017

16

1 reference

13 June 2017

797-808

1 reference

13 June 2017

7

1 reference

Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence

13 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900485-5

7 January 2021

Global epidemiology and genotype distribution of the hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900485-5

7 January 2021

Prevalence and estimation of hepatitis B and C infections in the WHO European Region: a review of data focusing on the countries outside the European Union and the European Free Trade Association

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900485-5

7 January 2021

Evolving epidemiology of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900485-5

7 January 2021

Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900485-5

7 January 2021

Current and emerging antiviral treatments for hepatitis C infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900485-5

7 January 2021

Viral hepatitis and HIV coinfection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900485-5

7 January 2021

Impact of human immunodeficiency virus infection in patients infected with the hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900485-5

7 January 2021

The natural history of hepatitis C virus infection: host, viral, and environmental factors

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900485-5

7 January 2021

Global epidemiology of hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900485-5

7 January 2021

Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900485-5

7 January 2021

Epidemiology of viral hepatitis and HIV co-infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900485-5

7 January 2021

Epidemiology of hepatitis C virus in HIV-infected patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900485-5

7 January 2021

Hepatitis B/C and HIV in sub-Saharan Africa: an association between highly prevalent infectious diseases. A systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900485-5

7 January 2021

Hepatitis C seroprevalence and HIV co-infection in sub-Saharan Africa: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900485-5

7 January 2021

Is the HCV-HIV co-infection prevalence amongst injecting drug users a marker for the level of sexual and injection related HIV transmission?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900485-5

7 January 2021

Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the HCV-HIV International Panel

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900485-5

7 January 2021

Diagnosis, management, and treatment of hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900485-5

7 January 2021

Management and treatment of hepatitis C virus infection in HIV-infected adults: recommendations from the Veterans Affairs Hepatitis C Resource Center Program and National Hepatitis C Program Office

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900485-5

7 January 2021

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900485-5

7 January 2021

Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900485-5

7 January 2021

Risk factors for human immunodeficiency virus infection among blood donors in Sao Paulo, Brazil, and their relevance to current donor deferral criteria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900485-5

7 January 2021

Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900485-5

7 January 2021

Hepatitis C virus infection epidemiology among people who inject drugs in Europe: a systematic review of data for scaling up treatment and prevention

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900485-5

7 January 2021

Hepatitis C in hospital employees with needlestick injuries

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900485-5

7 January 2021

HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900485-5

7 January 2021

Can antiviral therapy for hepatitis C reduce the prevalence of HCV among injecting drug user populations? A modeling analysis of its prevention utility

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900485-5

7 January 2021

The hepatitis C epidemic among HIV-positive MSM: incidence estimates from 1990 to 2007.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900485-5

7 January 2021

Hepatitis C virus infections in the Swiss HIV Cohort Study: a rapidly evolving epidemic

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900485-5

7 January 2021

Hepatitis C virus reinfection incidence and treatment outcome among HIV-positive MSM.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900485-5

7 January 2021

Prevalence of transfusion transmitted infections in blood donors: an Indian experience

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900485-5

7 January 2021

HCV and HIV co-infection in pregnant women attending St. Camille Medical Centre in Ouagadougou (Burkina Faso).

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900485-5

7 January 2021

Global estimates of prevalence of HCV infection among injecting drug users.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900485-5

7 January 2021

Prevalence of HIV, Hepatitis B and C Infections and an Assessment of HCV-Genotypes and Two IL28B SNPs among People Who Inject Drugs in Three Regions of Nepal

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900485-5

7 January 2021

Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900485-5

7 January 2021

Injecting drug users with chronic hepatitis C: should they be offered antiviral therapy?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900485-5

7 January 2021

10.1016/S1473-3099(15)00485-5

Identifiers

DOI

1 reference

13 June 2017

1 reference